Deciphering the role of LNK and its contribution to the pathogenesis of obesity-induced insulin resistance is of importance since it may be a new potential target for innovative therapeutic strategies. The gene discussed is SH2B3; the disease is obesity due to melanocortin 4 receptor deficiency.